Chris Marlett
Vorstandsvorsitzender bei MDB CAPITAL HOLDINGS, LLC
Vermögen: 35 Mio $ am 30.04.2024
Profil
Christopher Anthony Marlett is the founder of PatentVest, Inc. (founded in 2003), Public Ventures LLC (founded in 1997), and MDB Capital Holdings LLC (founded in 1997).
He is currently a Director at Invizyne Technologies, Inc. (since 2019).
He has also held positions as a Director at Orion Acquisition Corp.
II, The Arena Group Holdings, Inc., and Cue Biopharma, Inc. Mr. Marlett obtained his undergraduate degree from the University of Southern California in 1986.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MDB CAPITAL HOLDINGS LLC
75,10% | 29.03.2024 | 3 755 000 ( 75,10% ) | 34 Mio $ | 30.04.2024 |
| 29.03.2024 | 79 933 ( 1,86% ) | 719 397 $ | 30.04.2024 | |
HEARTBEAM, INC.
0,01% | 20.08.2023 | 3 911 ( 0,01% ) | 7 689 $ | 30.04.2024 |
Aktive Positionen von Chris Marlett
| Unternehmen | Position | Beginn |
|---|---|---|
| MDB CAPITAL HOLDINGS, LLC | Vorstandsvorsitzender | 01.01.1997 |
Public Ventures LLC
 Public Ventures LLC Investment Banks/BrokersFinance Public Ventures LLC is a registered broker-dealer headquartered in Dallas, Texas. The firm was founded by Christopher Marlett and Anthony DiGiandomenico in 1997. They are a wholly-owned subsidiary of MDB Capital Holdings LLC. Public Ventures offers Go-to-Market Strategy, Market Assessments, Revenue Generation and Product Strategy for technology companies that targets the Public Sector. | Vorstandsvorsitzender | 01.01.1997 |
Invizyne Technologies, Inc.
 Invizyne Technologies, Inc. Chemicals: SpecialtyProcess Industries Invizyne Technologies, Inc. is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV. | Direktor/Vorstandsmitglied | 01.04.2019 |
Ehemalige bekannte Positionen von Chris Marlett
| Unternehmen | Position | Ende |
|---|---|---|
| CUE BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 09.02.2020 |
| THE ARENA GROUP HOLDINGS, INC. | Vorstandsvorsitzender | 04.11.2016 |
| Orion Acquisition Corp. II | Direktor/Vorstandsmitglied | 20.05.2005 |
| PatentVest, Inc. | Gründer | - |
Ausbildung von Chris Marlett
| University of Southern California | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| THE ARENA GROUP HOLDINGS, INC. | Technology Services |
| CUE BIOPHARMA, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
| Orion Acquisition Corp. II | Finance |
Public Ventures LLC
Public Ventures LLC Investment Banks/BrokersFinance Public Ventures LLC is a registered broker-dealer headquartered in Dallas, Texas. The firm was founded by Christopher Marlett and Anthony DiGiandomenico in 1997. They are a wholly-owned subsidiary of MDB Capital Holdings LLC. Public Ventures offers Go-to-Market Strategy, Market Assessments, Revenue Generation and Product Strategy for technology companies that targets the Public Sector. | Finance |
| PatentVest, Inc. | |
| MDB Capital Holdings LLC | |
Invizyne Technologies, Inc.
Invizyne Technologies, Inc. Chemicals: SpecialtyProcess Industries Invizyne Technologies, Inc. is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV. | Process Industries |
